Zhongping Xie
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Standardized neutralizing antibody assay for Coxsackievirus A10 in clinical trial: A framework for multivalent hand, foot, and mouth disease vaccine evaluation.
Journal: Human vaccines & immunotherapeutics
Published: March 19, 2026
Research progress in the structural design of virus-like particle vaccines
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: February 27, 2026
A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines.
Journal: Emerging microbes & infections
Published: February 23, 2024
SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage.
Journal: Journal of medical virology
Published: January 27, 2023
Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques.
Journal: Signal transduction and targeted therapy
Published: April 13, 2022
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Journal: Signal transduction and targeted therapy
Published: January 23, 2022
Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells.
Journal: Journal of medical virology
Published: November 29, 2021
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
Journal: Emerging microbes & infections
Published: October 20, 2021
A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
Journal: Journal of medical virology
Published: August 23, 2021
Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 31, 2021
Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
Journal: Vaccine
Published: February 28, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
Journal: Vaccine
Published: January 07, 2021
Last Updated: 09/26/2026